Suheung Co., Ltd. (008490.KS)
- Previous Close
18,500.00 - Open
18,670.00 - Bid 18,970.00 x --
- Ask 19,000.00 x --
- Day's Range
18,300.00 - 19,250.00 - 52 Week Range
11,920.00 - 23,000.00 - Volume
163,299 - Avg. Volume
37,319 - Market Cap (intraday)
210.929B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Aug 11, 2025 - Aug 15, 2025
- Forward Dividend & Yield 200.00 (1.08%)
- Ex-Dividend Date Dec 27, 2024
- 1y Target Est
15,000.00
Suheung Co., Ltd. engages in produces and sells hard and soft capsules. The company provides solid dosage forms, including hard and soft capsule, tablets, powder, granules; fluidity and concentrated liquids; gummy, sticky and water jellies. It offers medical supplies, such as prescription medicines; over-the-counter drugs comprising antipyretic-analgesics, cold medicine, digestive medicine, liver-treatment medicine, and nutritional supplements; and quasi-drugs, which includes low-content vitamin-cosmetic products, multi-vitamin, toothpaste, effervescent tablet, and chewable tablet. In addition, it provides its capsules under Embocaps brand name. The company was founded in 1973 and is headquartered in Cheongju-si, South Korea.
www.suheung.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 008490.KS
View MorePerformance Overview: 008490.KS
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 008490.KS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 008490.KS
View MoreValuation Measures
Market Cap
205.70B
Enterprise Value
596.77B
Trailing P/E
10.77
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.31
Price/Book (mrq)
0.45
Enterprise Value/Revenue
0.89
Enterprise Value/EBITDA
6.57
Financial Highlights
Profitability and Income Statement
Profit Margin
2.85%
Return on Assets (ttm)
2.05%
Return on Equity (ttm)
4.40%
Revenue (ttm)
668.77B
Net Income Avi to Common (ttm)
19.09B
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
53.71B
Total Debt/Equity (mrq)
87.78%
Levered Free Cash Flow (ttm)
20.13B